Jounce Therapeutics: Q1 Earnings Insights

Jounce Therapeutics JNCE reported its Q1 earnings results on Thursday, May 5, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

Earnings

Jounce Therapeutics missed estimated earnings by 26.32%, reporting an EPS of $-0.72 versus an estimate of $-0.57.

Revenue was down $1.54 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.27 which was followed by a 4.16% drop in the share price the next day.

Here's a look at Jounce Therapeutics's past performance:

To track all earnings releases for Jounce Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.